Urapidil reduces elevated pulmonary vascular resistance in patients before heart transplantation
- 1 March 2002
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 21 (3) , 347-353
- https://doi.org/10.1016/s1053-2498(01)00381-3
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- UrapidilDrugs, 1998
- Effect of Bolus Milrinone on Hemodynamic Variables and Pulmonary Vascular Resistance in Patients With Severe Left Ventricular Dysfunction: A Rapid Test for Reversibility of Pulmonary HypertensionJournal of the American College of Cardiology, 1996
- Impact of Medical Therapy on Pulmonary Hypertension in Patients With Congestive Heart Failure Awaiting Cardiac TransplantationThe American Journal of Cardiology, 1996
- Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantationJournal of the American College of Cardiology, 1995
- Effects of Single Intravenous Administration of Urapidil and Diltiazem in Patients with Nonfixed Pulmonary Hypertension Secondary to Chronic Obstructive Lung DiseaseJournal of Cardiovascular Pharmacology, 1994
- Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: The Pittsburgh experienceAmerican Heart Journal, 1993
- Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: Comparative effects of various pharmacologic agentsAmerican Heart Journal, 1991
- Heart Transplantation in Patients with Severe Pulmonary Hypertension and Increased Pulmonary Vascular ResistanceScandinavian Journal of Thoracic and Cardiovascular Surgery, 1990
- Urapidil-induced hemodynamic changes in humansThe American Journal of Cardiology, 1989
- Haemodynamic Effects of Urapidil in Arterial Hypertension and Congestive Heart FailureDrugs, 1988